237
Participants
Start Date
November 11, 2021
Primary Completion Date
January 19, 2023
Study Completion Date
March 16, 2023
Lu AG09222
Lu AG09222 will be administered per schedule specified in the arm.
Placebo
Placebo matching to Lu AG09222 will be administered per schedule specified in the arm.
Rigshospitalet Glostrup-Nordre Ringvej 57, Glostrup Municipality
Aarhus Universitetshospital, Aarhus N
UNISON Clinical Trials (Shahram Jacobs md inc.), Sherman Oaks
Excell Research - ClinEdge - PPDS, Oceanside
Allied Biomedical Research Institute, Miami
CCR Ostrava s.r.o., Ostrava
Mestska nemocnice Ostrava, p.o., Ostrava
CCR Czech, Pardubice
CCR Prague s.r.o., Prague
Fakultni nemocnice u sv. Anny v Brne, Brno
NEUROHK, s.r.o., Choceň
FORBELI s.r.o., Prague
INEP Medical s.r.o., Prague
CLINTRIAL s.r.o., Prague
Ltd Israel-Georgia Medical Research Clinic Helsicore, Tbilisi
Archangel St Michael Multiprofile Clinical Hospital Ltd, Tbilisi
Aversi Clinic LTD, Tbilisi
LTD MediClubGeorgia, Tbilisi
Malkhaz Katsiashvili Multiprofile Emergency Medicine Center, Tbilisi
"Ltd Multiprofile Clinic Consilium Medulla", Tbilisi
Solumed SC, Poznan
Pratia MCM, Krakow
Instytut Zdrowia Dr Boczarska-Jedynak, Oświęcim
ETG Singua - PPDS, Warsaw
Centrum Medyczne Silmedic Sp z o o, Katowice
MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak, Wroclaw
MUDr. Beata Dupejova, Neurologicka ambulancia, s.r.o., Banská Bystrica
KONZILIUM s.r.o, Dubnica nad Váhom
H. Lundbeck A/S
INDUSTRY